- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05987891
Cardiovascular Risk Factors on Electrocardiographically and Hemodynamics Responses to Treadmill Exercise Test (ERGO-RISC)
June 2, 2025 updated by: Pedro Gabriel Senger Braga, University of Sao Paulo
The Influence of Cardiovascular Risk Factors on Electrocardiographically and Hemodynamics Responses to Treadmill Exercise Test in Asymptomatically Subjects: a Clinical Perspective (ERGO-RISC)
The goal of this observational cross-sectional study is to analyze the effect of cardiovascular risk factors in healthy and asymptomatic populations. The main questions it aims to answer are:
- Does the combination of the presence of different risk factors increase the risk for abnormalities appearing on electrocardiograms, such as ischemia, arrhythmia, and hemodynamics effects during and at the peak of effort of treadmill exercise test?
- What are the main differences observed in the recovery period? Participants will answer an anamnesis of risk factors such as sex, race, age, familiar history of coronary artery disease, overweight or obesity, smoking, stress, and physical activity practice and perform treadmill exercise test on Ellestad protocol. If there a comparison groups: Researchers will compare individuals with most risk factors with those without, to see the cardiovascular responses.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The main outcomes broad the effect of simples and easy doccumented cardiovascular risk factors such as sex, race, age, familiar history of coronary artery disease, overweight or obesity, smoking, stress, and physical inactivity on electrocardiogram and hemodinamics abnormalities during and after exercise treadmill exercise test.
Study Type
Observational
Enrollment (Actual)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05021-010
- Pró-Coração
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy and assymptomatically subjects who are visiting cardiologyst for routine.
Description
Inclusion Criteria:
- Subjects that can complete the treadmill exercise test with the Ellestad protocol with 6 minutes of recovery.
Exclusion Criteria:
- Use of remedies for blood pressure, glycemia, cholesterol, and serum lipids;
- Symptomatically subjects;
- Electrocardiogram that are not able to be interpreted;
- Blood pressure in rest state ≥180 mmHg and ≥110 mmHg, for systolic and diastolic, respectively.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy controls
Volunteers will perform treadmill exercise tests.
It will be monitored electrocardiogram, heart rate, and blood pressure in the rest state, under exercise, and in the recovery.
|
Ellestad protocol will be applied in all subjects up to fatigue and recovery will be monitored.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ECG abnormalities and risk factors
Time Frame: 1 year
|
Electrocardiogram suggestive of myocardial ischemia
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2023
Primary Completion (Actual)
March 26, 2025
Study Completion (Actual)
March 26, 2025
Study Registration Dates
First Submitted
July 25, 2023
First Submitted That Met QC Criteria
August 3, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Estimated)
June 5, 2025
Last Update Submitted That Met QC Criteria
June 2, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pró-Coração
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Treadmill exercise stress test
-
Icahn School of Medicine at Mount SinaiRecruitingAngina | Non-obstructive Coronary Artery DiseaseUnited States
-
LHL HelseCompletedCOPD | Myocardial DiseasesNorway
-
Duke UniversityTerminatedPathologically Proven Gastrointestinal Malignancy | Plan of Care Must Include ChemoradiationUnited States
-
Istanbul Medeniyet UniversityCompletedMenstrual Cycle | Exercise TreadmillTurkey (Türkiye)
-
M.D. Anderson Cancer CenterUnknownLung CancerUnited States
-
Freeman-Sheldon Research Group, Inc.CompletedObesity | Gender | Problem of AgingUnited States
-
University Health Network, TorontoWithdrawn
-
University of MiamiCompletedParkinson Disease | Autonomic DysfunctionUnited States
-
University at BuffaloCompleted
-
UMC UtrechtCenter for Man in Aviation, Royal Netherlands Air ForceTerminatedOccupational Diseases | Coronary Artery Calcification | Coronary Artery Disease (CAD) | Aviator's; DiseaseNetherlands